Controversy builds over potent new opioid medication as U.S. senator calls on FDA to reject the drug

Controversy builds over potent new opioid medication as U.S. senator calls on FDA to reject the drug
A new, potent opioid medication intended for immediate pain relief has become the center of a maelstrom of controversy as it nears a Food and Drug Administration approval decision early next month. The latest salvo came from Sen. Edward Markey (D-Mass.) on Thursday, calling on the FDA to reject the medication as it is “a thousand times more likely to... Read More

Sanofi dengue vaccine gets recommendation for European approval

Sanofi dengue vaccine gets recommendation for European approval
Sanofi S.A.’s dengue vaccine, Dengvaxia, has been recommended for approval in Europe by the European Medicines Agency’s Committee for Medicinal Products for Human Use, the company said early Friday. Dengue is a viral disease that is spread by mosquitoes and has moved quickly in many parts of the world. Because there are four related viruses that cause dengue, an individual... Read More

Energy, IT Stocks Drag TSX Lower

Energy, IT Stocks Drag TSX Lower
The Canadian stock market ended modestly lower on Wednesday, after trading in negative territory right through the session, weighed down by lower commodity prices and largely sluggish U.S. and European markets. Information technology, energy and healthcare stocks were among the prominent losers. Industrial and materials stocks too were mostly weak. Financial stocks found modest support, while consumer discretionary and real... Read More

Profit Taking May Lead To Pullback On Wall Street

Profit Taking May Lead To Pullback On Wall Street
The major U.S. index futures are pointing to a lower opening on Wednesday, with stocks likely to give back ground after moving sharply higher in the previous session. Profit taking may contribute to initial weakness on Wall Street, as traders cash in on yesterday’s gains amid lingering uncertainty about the near-term outlook for the markets. A negative reaction to the... Read More

Asian Shares Edge Higher After Wall Street Rally

Asian Shares Edge Higher After Wall Street Rally
Asian stocks climbed on Wednesday after U.S. shares posted their biggest gain in six months overnight following strong earnings from major financial and health care companies as well as encouraging reports on the U.S. economy. Chinese shares closed higher ahead of third-quarter GDP and September activity data, due on Friday. The benchmark Shanghai Composite index gained 0.60 percent to finish... Read More

Stocks Move Sharply Higher On Upbeat Earnings, Economic News – U.S. Commentary

Stocks Move Sharply Higher On Upbeat Earnings, Economic News – U.S. Commentary
Following the pullback in the previous session, stocks moved sharply higher over the course of the trading day on Tuesday. The major averages more than offset yesterday’s losses, extending the rebound seen last Friday. The major averages ended the session just off their best levels of the day. The Dow surged up 547.87 points or 2.2 percent to 25,798.42, the... Read More

Dow jumps by more than 500 points at peak, putting blue chips on track for best day since March

Dow jumps by more than 500 points at peak, putting blue chips on track for best day since March
The Dow Jones Industrial Average was trading sharply higher midday Tuesday, putting blue chips on track to book the best one-day gain since March. The Dow DJIA, +1.92% was up about 492 points, or 2%, at 25,739. If it holds the gain would represent the best point and percentage climb since March 26. Tuesday’s rally was partly on the back... Read More

S&P 500 retakes 2,800 mark intraday amid broad stock-market surge

S&P 500 retakes 2,800 mark intraday amid broad stock-market surge
The S&P 500 Tuesday afternoon regained its purchase atop a psychologically significant level at 2,800, on the back of a health-care and technology-inspired stock rally. The S&P 500 SPX, +1.80% most recently, was up 1.9% at 2,802, returning to a level the broad-market benchmark lost grip on during a nasty Oct. 10 rout. The S&P 500 has declined seven of... Read More